BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10466241)

  • 1. [Treatment of metastatic breast carcinoma].
    Puglisi F; Sobrero A
    Ann Ital Chir; 1999; 70(3):377-89. PubMed ID: 10466241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The curability of breast cancer and the treatment of advanced disease.
    Guarneri V; Conte PF
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing endocrine therapy for premenopausal and postmenopausal women with breast cancer.
    Cianfrocca M; Wolff AC
    Oncology (Williston Park); 2007 Jan; 21(1):63-9; discussion 69, 72, 75 passim. PubMed ID: 17313157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in breast oncology: the 2002 ASCO meeting.
    Singh-Ranger G; Mokbel K;
    Curr Med Res Opin; 2002; 18(7):401-6. PubMed ID: 12487506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer (metastatic).
    Stebbing J; Crane J; Gaya A
    Clin Evid; 2006 Jun; (15):2331-59. PubMed ID: 16973089
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
    ; Thürlimann B; Keshaviah A; Coates AS; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Rabaglio M; Smith I; Wardley A; Price KN; Goldhirsch A
    N Engl J Med; 2005 Dec; 353(26):2747-57. PubMed ID: 16382061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer.
    Piccart MJ; Cardoso F; Atalay G
    Eur J Cancer; 2002 Nov; 38 Suppl 6():S52-4. PubMed ID: 12409074
    [No Abstract]   [Full Text] [Related]  

  • 8. An overview of letrozole in postmenopausal women with hormone-responsive breast cancer.
    Barnadas A; Estévez LG; Lluch-Hernández A; Rodriguez-Lescure A; Rodriguez-Sanchez C; Sanchez-Rovira P
    Adv Ther; 2011 Dec; 28(12):1045-58. PubMed ID: 22068628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metastatic breast cancer: what are the objectives?].
    Salvini P; Ripa C; Ginanni V
    Tumori; 2000; 86(5 Suppl 1):S22-8. PubMed ID: 11195289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen.
    Ruddy KJ; DeSantis SD; Barry W; Guo H; Block CC; Borges V; Winer EP; Partridge AH
    Clin Breast Cancer; 2014 Dec; 14(6):413-6. PubMed ID: 24970714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letrozole: a pharmacoeconomic review of its use in postmenopausal women with breast cancer.
    Dunn C; Keam SJ
    Pharmacoeconomics; 2006; 24(5):495-517. PubMed ID: 16706574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer.
    Koeberle D; Thuerlimann B
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):5-10. PubMed ID: 16375638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letrozole: a review of its use in postmenopausal women with breast cancer.
    Simpson D; Curran MP; Perry CM
    Drugs; 2004; 64(11):1213-30. PubMed ID: 15161328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data.
    Grana G
    J Surg Oncol; 2006 Jun; 93(7):585-92. PubMed ID: 16705732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial.
    Goss PE
    Semin Oncol; 2006 Apr; 33(2 Suppl 7):S8-12. PubMed ID: 16730271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Introduction of new drug: letrozole, a new non-steroidal aromatase inhibitor for the treatment of postmenopausal women with breast cancer].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 2006 Jun; 33(6):859-63. PubMed ID: 16770112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress and perspectives in palliative therapy of breast carcinoma].
    Verlag GT
    Dtsch Med Wochenschr; 1996 Dec; 121(49 Suppl):1-8. PubMed ID: 8983911
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.
    Goss PE; Ingle JN; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Tu D; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Therasse P; Palmer MJ; Pater JL
    N Engl J Med; 2003 Nov; 349(19):1793-802. PubMed ID: 14551341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiestrogen treatment in postmenopausal patients with metastatic breast cancer].
    Lindberg H; Nielsen DL; Tuxen M; Kamby C
    Ugeskr Laeger; 2007 Sep; 169(37):3096-100. PubMed ID: 17877958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in endocrine therapy: anastrozole and advanced breast cancer in postmenopausal women.
    Nabholtz JM
    Am J Hosp Palliat Care; 2004; 21(6):457-65. PubMed ID: 15612238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.